tiprankstipranks
Trending News
More News >
Banka BioLoo Ltd. (IN:BANKA)
:BANKA
India Market
Advertisement

Banka BioLoo Ltd. (BANKA) AI Stock Analysis

Compare
0 Followers

Top Page

IN:BANKA

Banka BioLoo Ltd.

(BANKA)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 4o)
Rating:44Neutral
Price Target:
₹82.00
▼(-5.96% Downside)
Banka BioLoo Ltd. faces significant financial challenges, with declining revenues and profitability, negative cash flows, and a negative P/E ratio. Technical analysis provides mixed signals, with some indicators suggesting potential oversold conditions. The absence of earnings call data and corporate events limits further insights. Overall, the stock is under pressure, with financial performance being the most significant factor.

Banka BioLoo Ltd. (BANKA) vs. iShares MSCI India ETF (INDA)

Banka BioLoo Ltd. Business Overview & Revenue Model

Company DescriptionBanka BioLoo Limited provides products and services for sanitation and waste management system in India. It manufactures, supplies, and installs bio-toilets. The company is also involved in the operation and maintenance of bio-toilets for Indian railways; setting-up of fecal sludge treatment plants and packaged sewage treatment plants; and refurbishment of sewage treatment plants for complexes. The company was incorporated in 2012 and is based in Hyderabad, India.
How the Company Makes MoneyBanka BioLoo Ltd. generates revenue through the sale and installation of its bio-toilets and bio-digester systems. The company caters to both private and public sector clients, including Indian Railways, government bodies, and private organizations that require sustainable sanitation solutions. Additionally, Banka BioLoo may earn revenue from maintenance contracts and after-sales services associated with its bio-toilets and related infrastructure. The company’s strategic partnerships with government agencies and its involvement in public sanitation projects contribute significantly to its earnings by ensuring a steady demand for its products and services.

Banka BioLoo Ltd. Financial Statement Overview

Summary
Banka BioLoo Ltd. is experiencing significant financial challenges, with declining revenues, negative profitability, and cash flow difficulties. The balance sheet shows a moderate debt-to-equity ratio, but the overall financial health is under pressure due to shrinking equity and persistent losses.
Income Statement
40
Negative
Banka BioLoo Ltd. has experienced a decline in revenue and profitability over the years. The gross profit margin has decreased significantly from a strong position, and the company is currently reporting negative EBIT and net income, indicating challenges in profitability and operational efficiency. The revenue growth rate has been negative in the most recent year, highlighting a contraction in sales.
Balance Sheet
55
Neutral
The balance sheet shows a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the stockholders' equity has been decreasing, reflecting potential financial strain. The equity ratio remains stable but does not offset the risks associated with declining equity and increasing liabilities.
Cash Flow
35
Negative
Cash flow analysis reveals a negative free cash flow, indicating the company's inability to generate sufficient cash to cover its capital expenditures. The operating cash flow has also turned negative recently, which is concerning for sustaining operations without external financing. The free cash flow to net income ratio is unfavorable, pointing towards cash flow difficulties.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue524.29M541.74M499.96M423.50M387.51M304.58M
Gross Profit248.99M9.87M337.57M368.11M320.30M266.47M
EBITDA-32.98M-28.60M41.85M68.94M58.91M40.24M
Net Income-91.94M-89.09M-6.53M25.39M31.08M22.05M
Balance Sheet
Total Assets0.00821.55M774.23M652.07M640.54M463.71M
Cash, Cash Equivalents and Short-Term Investments46.49M40.70M16.88M13.41M8.29M43.35M
Total Debt0.00347.28M259.13M167.15M184.96M116.99M
Total Liabilities-315.85M505.70M376.61M251.09M265.52M163.43M
Stockholders Equity315.85M315.13M397.20M400.99M375.02M300.28M
Cash Flow
Free Cash Flow0.00-69.53M-72.06M9.40M-36.00M53.55M
Operating Cash Flow0.00-24.71M27.63M73.53M-4.40M58.64M
Investing Cash Flow0.00-63.44M-100.69M-57.18M-27.17M-283.29K
Financing Cash Flow0.0087.50M67.76M-33.29M9.55M-36.86M

Banka BioLoo Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price87.20
Price Trends
50DMA
87.80
Negative
100DMA
78.88
Positive
200DMA
80.79
Positive
Market Momentum
MACD
-0.48
Positive
RSI
50.21
Neutral
STOCH
17.77
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BANKA, the sentiment is Positive. The current price of 87.2 is below the 20-day moving average (MA) of 87.72, below the 50-day MA of 87.80, and above the 200-day MA of 80.79, indicating a neutral trend. The MACD of -0.48 indicates Positive momentum. The RSI at 50.21 is Neutral, neither overbought nor oversold. The STOCH value of 17.77 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BANKA.

Banka BioLoo Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹6.77B34.526.64%0.71%5.42%-35.75%
52
Neutral
₹4.29B39.644.18%13.71%
44
Neutral
₹945.82M-3.99%-567.52%
36
Underperform
₹3.77B-33.700.15%-4.18%82.74%
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:BANKA
Banka BioLoo Ltd.
87.32
-24.41
-21.85%
IN:IL&FSENGG
IL&FS Engineering & Construction Co. Ltd.
27.35
-20.00
-42.24%
IN:INTLTRAVHS
International Travel House Limited
472.35
-130.09
-21.59%
IN:MAHEPC
Mahindra EPC Irrigation Limited
152.25
24.05
18.76%
IN:SAYAJIHOTL
Sayaji Hotels Limited
290.00
-57.00
-16.43%
IN:SPECIALITY
Speciality Restaurants Ltd.
140.25
-27.13
-16.21%

Banka BioLoo Ltd. Corporate Events

Banka BioLoo Releases Financial Results for June 2025 Quarter
Aug 9, 2025

Banka BioLoo Limited announced the publication of its unaudited financial results for the quarter ending June 30, 2025, in prominent newspapers, complying with regulatory requirements. This timely disclosure underscores the company’s commitment to transparency and may influence stakeholder confidence as it highlights the company’s operational performance and financial health.

Banka BioLoo to Hold 13th AGM Virtually
Aug 9, 2025

Banka BioLoo Limited has announced that its 13th Annual General Meeting will be conducted via video conferencing on September 10, 2025. This move aligns with regulatory requirements and ensures shareholder engagement while adhering to safety protocols. The decision to hold the AGM virtually reflects the company’s adaptability and commitment to maintaining transparent communication with its stakeholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2025